An exploratory clinical trial of apatinib combined with intensity‐modulated radiation therapy for patients with unresectable hepatocellular carcinoma
Abstract Purpose To evaluate the clinical efficacy and safety of apatinib combined with intensity‐modulated radiation therapy (IMRT) in patients with unresectable hepatocellular carcinoma (uHCC). Materials and methods Open‐label, single‐arm, exploratory clinical trial of apatinib combined with IMRT...
Main Authors: | Hu Qiu, Shaobo Ke, Gaoke Cai, Yong Wu, Jin Wang, Wei Shi, Jiamei Chen, Jin Peng, Baoping Yu, Yongshun Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.4900 |
Similar Items
-
Phase 1 trial of apatinib combined with intensity-modulated radiotherapy in unresectable hepatocellular carcinoma
by: Hongzhi Wang, et al.
Published: (2022-07-01) -
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular Carcinoma
by: Zhang W, et al.
Published: (2021-07-01) -
Transarterial chemoembolization plus apatinib with or without camrelizumab for unresected hepatocellular carcinoma: A two-center propensity score matching study
by: Di Zhu, et al.
Published: (2022-11-01) -
Therapeutic effect of apatinib-loaded nanoparticles on diabetes-induced retinal vascular leakage
by: Jeong JH, et al.
Published: (2016-07-01) -
Efficacy Of Apatinib In Transcatheter Arterial Chemoembolization (TACE) Refractory Intermediate And Advanced-Stage Hepatocellular carcinoma:A Propensity Score Matching Analysis
by: Qiu Z, et al.
Published: (2019-11-01)